Table 1

The changing trends of number of prevalent cases and prevalence rate of NAFLD from 1990 to 2017

199020171990–2017*
No. of cases
(×1 million)
Prevalence
(%)‡
No. of cases
(×1 million)
Prevalence
(%)
EAPC (95% CI)
Overall391.28.2882.110.91.05 (1.04 to 1.07)
Sex
 Male236.410.0524.013.21.00 (0.99 to 1.02)
 Female154.86.4358.18.71.12 (1.10 to 1.13)
Sociodemographic Index
 High76.26.7137.49.01.14 (1.06 to 1.21)
 High-middle100.29.4224.513.11.21 (1.17 to 1.25)
 Middle120.09.4282.312.20.94 (0.92 to 0.96)
 Middle-low62.38.0157.110.51.01 (1.00 to 1.02)
 Low30.46.576.27.90.74 (0.70 to 0.79)
Age (years)†
 15–49241.58.8489.112.51.25 (1.22 to 1.28)
 50–69109.115.9281.521.41.06 (1.04 to 1.08)
 ≥7040.720.0111.425.70.93 (0.89 to 0.96)
GBD region
 Andean Latin America2.58.87.112.01.13 (1.10 to 1.16)
 Australasia1.56.43.18.61.16 (1.04 to 1.28)
 Caribbean2.89.25.811.71.03 (0.98 to 1.07)
 Central Asia3.86.77.48.50.91 (0.81 to 1.01)
 Central Europe9.56.713.18.00.70 (0.67 to 0.73)
 Central Latin America12.710.536.514.41.17 (1.14 to 1.21)
 Central sub-Saharan Africa2.36.56.27.50.58 (0.50 to 0.67)
 East Asia111.89.6242.812.60.88 (0.82 to 0.95)
 Eastern Europe18.47.023.78.40.73 (0.64 to 0.82)
 Eastern sub-Saharan Africa7.16.018.07.00.58 (0.55 to 0.60)
 High-income Asia Pacific11.45.718.77.00.78 (0.75 to 0.82)
 High-income North America23.17.244.09.61.17 (1.06 to 1.29)
 North Africa and Middle East35.014.3108.019.31.12 (1.10 to 1.15)
 Oceania0.612.81.616.30.90 (0.87 to 0.92)
 South Asia53.66.4131.28.00.81 (0.78 to 0.83)
 Southeast Asia39.510.998.514.51.12 (1.08 to 1.15)
 Southern Latin America3.16.56.38.61.05 (1.01 to 1.08)
 Southern sub-Saharan Africa3.79.38.111.40.73 (0.69 to 0.77)
 Tropical Latin America9.88.026.711.11.17 (1.15 to 1.19)
 Western Europe30.96.552.18.91.17 (1.05 to 1.29)
 Western sub-Saharan Africa8.46.523.28.00.69 (0.63 to 0.75)
  • *The prevalence has been standardised by age.

  • †Crude prevalence rate for each age group.

  • ‡P values of all EAPCs were <0.001.

  • EAPC, estimated annual percentage change; GBD, Global Burden of Disease; NAFLD, non-alcoholic fatty liver disease.